| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.36 | 0.04 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |